Explore more publications!

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on November 3, 2025

Sarasota’s Hidden Health Threat Is Mold: MDLifespan Partners with Dr. Christopher Davis to Launch Detox Program
Shriners Children’s Unveils New Podcast Highlighting Innovations in Pediatric Care
ProMD Medical Billing Named a Top Medical Billing Company in 2025 by Healthcare Business Review
American Hindu-Jewish Congress Gala Unites Leaders to Champion Mental Health Awareness
GrassRoots Medical Marketing Strengthens SEO Leadership to Navigate AI’s Disruption of Patient Search
Institute for Mobility and Longevity & Gardner Orthopedics Welcome Dr. Ramires as 2025–2026 Adult Reconstruction Fellow
Lakeland Palms Shine in All Florida Pickleball League, Winning 3 of 5 Stops and Celebrating Player’s PPA Contract
Advantage Anywhere and Tres Software Announce Partnership Delivering a Complete CRM + eMAR Solution for Senior Living
South Florida’s Providence Healthcare Services Named One of America’s Best Home Health Agencies by Newsweek
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Flo Health and Dr. Sameena Rahman Address Perimenopause and Its Workplace Impact with YourUpdateTV
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
Olema Oncology to Participate in Upcoming Investor Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions